|
|
Build Your Online Product Catalogs?
| Product Name: |
milk thistle extract, milk thistle P.E,silymarin 80%, USP34,EP7
|
| Supply Ability: |
200t/year |
| Related proudcts |
silybin, silymarin, milk thistle, |
| Specifications |
UV80% |
| Price Term: |
FOB,CNF,CIF |
| Port of loading: |
DALIAN,TIANJIN,QINGDAO,SHANGHAI,NINGBO,SHENZHEN |
| Minimum Order |
1KG |
| Unit Price: |
USD37/KG |
|
Product Introduction
Milk thistle originally is from Europe, the ingredient responsible for milk thistle's medicinal qualities is called silymarin. Silymarin is a flavonolignan that has been introduced fairly recently as a hepatoprotective agent, it is the most well known compound of the flavonoids, thanks to its well defined therapeutic properties, and in reality it is a mixture of three structural components: silybin, silydianine and silychristine, studies in animals have shown that silymarin promotes the following activities:
Liver Cell Growth ------ Silymarin from milk thistle appears to promote the growth of some types of cells in the liver. Milk thistle is not used to prevent Hepatitis C Virus from causing liver disease. Rather, milk thistle is used with the hope that it would minimize the damage to the liver that HCV can cause.
Antioxidation ------ Milk thistle Silymarin may be an effective "antioxidant," which means milk thistle may help fight a destructive chemical process in the body known as "oxidation." In oxidation, harmful substances produced in the body (called free radicals) can damage cells. Some studies suggest that milk thistle silymarin can prevent these substances from damaging liver cells.
Inflammation Inhibition ------ Milk thistle's Silymarin is thought to prevent inflammation (swelling) of the liver; this may be described as displaying anti-inflammatory properties.
Silybin is the major active constituent of silymarin, both in vitro and animal research suggest that silibinin has hepatoprotective (antihepatotoxic) properties that protect liver cells against toxins, has also demonstrated anti-cancer effects against human prostate adenocarcinoma cells, estrogen-dependent and -independent human breast carcinoma cells,etc.
|
| Company: |
Panjin Huacheng Pharmaceutical Co., Ltd
|
| Contact: |
Ms. Lucy Lee |
| Address: |
Dongfeng town, DawaDistrict |
| Postcode: |
124000 |
| Tel: |
8615642701213 |
| Fax: |
|
| E-mail: |
|
|
|
|
Home
